Vertex Pharmaceuticals, Inc. (VRTX)

438.98 -2.38 (-0.54%) USD  |  NASDAQ  |  Jan 20, 12:55
More

Vertex Pharmaceuticals Other Long Term Assets (Quarterly)

Other Long Term Assets (Quarterly) Chart

View Other Long Term Assets (Quarterly) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Assets (Quarterly) Range, Past 5 Years

View Other Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Assets (Quarterly) Benchmarks

View Other Long Term Assets (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade